Cardio Diagnostics Holdings (CDIO) Net Margin (2022 - 2026)

Cardio Diagnostics Holdings has disclosed Net Margin across 5 years of filings, most recently posting 28012.46% for Q2 2026.

• In Q2 2026, Net Margin fell 549475.0% year-over-year to 28012.46%; the TTM figure through Jun 2026 stood at 44771.83% (down 1273135.0% YoY), while the FY2025 annual figure was 34627.67%, down 1059943.0% from the prior year.
• Net Margin came in at 28012.46% for Q2 2026 at Cardio Diagnostics Holdings, up from 66722.31% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 16365.88% in Q2 2024 to a low of 250321.79% in Q4 2022.
• Average Net Margin over 5 years is 72790.84%, with a median of 30842.53% recorded in 2024.
• Year-over-year, Net Margin jumped 22416493 bps in 2023 and tumbled 14780295 bps in 2025.
• Over 5 years, Net Margin stood at 250321.79% in 2022, then jumped by 90 bps to 26156.85% in 2023, then dropped by 29 bps to 33672.61% in 2024, then retreated by 22 bps to 41219.92% in 2025, then soared by 32 bps to 28012.46% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 28012.46% in Q2 2026, 66722.31% in Q1 2026, and 41219.92% in Q4 2025.